D.E. Shaw & Co’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Sell |
51,324
-4,717
| -8% | -$38.4K | ﹤0.01% | 2579 |
|
|
2025
Q1 | $440K | Buy |
+56,041
| New | +$440K | ﹤0.01% | 2509 |
|
|
2024
Q4 | – | Sell |
-13,501
| Closed | -$206K | – | 3314 |
|
|
2024
Q3 | $206K | Sell |
13,501
-17,264
| -56% | -$264K | ﹤0.01% | 2806 |
|
|
2024
Q2 | $469K | Sell |
30,765
-36,777
| -54% | -$560K | ﹤0.01% | 2517 |
|
|
2024
Q1 | $1.28M | Buy |
+67,542
| New | +$1.28M | ﹤0.01% | 1986 |
|
|
2023
Q3 | – | Sell |
-9,995
| Closed | -$203K | – | 3225 |
|
|
2023
Q2 | $203K | Buy |
+9,995
| New | +$203K | ﹤0.01% | 2607 |
|
|
2023
Q1 | – | Sell |
-26,804
| Closed | -$554K | – | 3535 |
|
|
2022
Q4 | $554K | Buy |
+26,804
| New | +$554K | ﹤0.01% | 2679 |
|
|
2022
Q2 | – | Sell |
-44,087
| Closed | -$1.39M | – | 4395 |
|
|
2022
Q1 | $1.39M | Sell |
44,087
-288,907
| -87% | -$9.12M | ﹤0.01% | 2666 |
|
|
2021
Q4 | $13.5M | Buy |
332,994
+140,031
| +73% | +$5.67M | 0.01% | 927 |
|
|
2021
Q3 | $6.73M | Sell |
192,963
-161,983
| -46% | -$5.65M | 0.01% | 1272 |
|
|
2021
Q2 | $9.75M | Sell |
354,946
-204,363
| -37% | -$5.61M | 0.01% | 1073 |
|
|
2021
Q1 | $15.7M | Sell |
559,309
-10,024
| -2% | -$281K | 0.02% | 805 |
|
|
2020
Q4 | $14.8M | Sell |
569,333
-44,704
| -7% | -$1.16M | 0.01% | 809 |
|
|
2020
Q3 | $10.5M | Buy |
614,037
+168,755
| +38% | +$2.89M | 0.01% | 875 |
|
|
2020
Q2 | $11M | Buy |
+445,282
| New | +$11M | 0.01% | 830 |
|
|
2020
Q1 | – | Sell |
-33,100
| Closed | -$334K | – | 2822 |
|
|
2019
Q4 | $334K | Buy |
+33,100
| New | +$334K | ﹤0.01% | 2331 |
|